IDEAYA Biosciences (IDYA) Misses Q4 EPS by 149c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($1.49). Revenue for the quarter came in at $7 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put
• Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters